QIAGEN N.V.: Release of a capital market information

Post-admission Duties announcement

Venlo (pta022/10.08.2023/12:16 UTC+2)

Form 6-K for the quarterly period ended June 30, 2023

QIAGEN N.V. hereby announces that the Form 6-K Report of Foreign Private Issuer pursuant to rule 13a-16 OR 15d-16 of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2023, was filed with the United States Securities and Exchange Comission (SEC).

The document is now available on the website of QIAGEN:
https://s28.q4cdn.com/125951340/files/doc_financials/2023/q2/2023-Q2-6-K-Final-as-filed-08-09-2023.pdf

(end)

Emitter:	QIAGEN N.V. Hulsterweg 82 5912 PL Venlo Netherlands
Contact Person:	Investor Relations
Phone:	+31 7735566 - 00
E-Mail:	ir@qiagen.com
Website:	www.qiagen.com
ISIN(s):	NL0012169213 (Share)
Stock Exchange(s):	Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate
Other Stock Exchanges:	NYSE, SIX, BX Swiss